A High Profile Failure for Stimuvax: Lessons Learned and Future Prospects for Immunotherapy
Jan 08, 2013•8 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Dr. Jack West offers thoughts on the disappointing negative results of the START trial with the immunotherapy Stimuvax, and what this might mean as we anticipate the results of future trials of other immunotherapies moving forward in clinical trials in lung cancer.
For the best experience, listen in Metacast app for iOS or Android